SCHEMBL14715871

SCHEMBL14715871

CCCCCC(CC[C@@H]1[C@@H](Cc2cccc(OCc3ccccc3)c2)[C@@H](CO)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 1/20 0.32
▸ CYP4A11 Q02928 1/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ GMNN O75496 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ PTGS1 P23219 1/20 0.32
▸ PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20218870 1.00 CYP4F2 (0.32) CYP4F2CYP4A11MAPK1MEN1KMT2A
SCHEMBL14715868 1.00 CYP4F2 (0.32) CYP4F2CYP4A11MAPK1MEN1KMT2A
SCHEMBL14715869 1.00 CYP4F2 (0.32) CYP4F2CYP4A11MAPK1MEN1KMT2A
SCHEMBL14716058 0.86 CTRC (0.32) —
SCHEMBL14716061 0.86 CTRC (0.32) —
SCHEMBL14716060 0.86 CTRC (0.32) —
SCHEMBL14716104 0.84 BCHE (0.31) CYP4F2CYP4A11MEN1KMT2ABCHE
SCHEMBL14716101 0.84 BCHE (0.31) CYP4F2CYP4A11MEN1KMT2ABCHE
SCHEMBL14719739 0.84 BCHE (0.31) CYP4F2CYP4A11MEN1KMT2ABCHE
SCHEMBL14716102 0.84 BCHE (0.31) CYP4F2CYP4A11MEN1KMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130317245-A1 INTERMEDIATES FOR THE SYNTHESIS OF BENZINDENE PROSTAGLANDINS AND PREPARATIONS THEREOF CHIROGATE INTERNATIONAL INC. (TW) 2013-11-28 — — US disclosed
US-8524939-B2 Intermediates for the synthesis of benzindene prostaglandins and preparations thereof CHIROGATE INTERNATIONAL INC. (TW) 2013-09-03 — — US disclosed
US-20130053581-A1 INTERMEDIATES FOR THE SYNTHESIS OF BENZINDENE PROSTAGLANDINS AND PREPARATIONS THEREOF CHIROGATE INTERNATIONAL INC. 2013-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053581-A1 INTERMEDIATES FOR THE SYNTHESIS OF BENZINDENE PROSTAGLANDINS AND PREPARATIONS THEREOF PTGIS, PTGES, PTGS1 CYP4F2 264/4885CYP4A11 128/4885MAPK1 1739/4885
US-20130317245-A1 INTERMEDIATES FOR THE SYNTHESIS OF BENZINDENE PROSTAGLANDINS AND PREPARATIONS THEREOF PTGIS, PTGES, PTGS1 CYP4F2 264/4885CYP4A11 128/4885MAPK1 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback